Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Cardiovascular effects of… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Cardiovascular effects of ghrelin and growth hormone secretagogues.

Artikel i vetenskaplig tidskrift
Författare Jörgen Isgaard
Anna Barlind
Inger Johansson
Publicerad i Cardiovascular & hematological disorders drug targets
Volym 8
Nummer/häfte 2
Sidor 133-7
ISSN 1871-529X
Publiceringsår 2008
Publicerad vid Institutionen för medicin
Institutionen för medicin, avdelningen för invärtesmedicin
Sidor 133-7
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Animals, Cardiotonic Agents, pharmacology, therapeutic use, Cardiovascular Diseases, drug therapy, physiopathology, Cardiovascular System, metabolism, physiopathology, Clinical Trials as Topic, Disease Models, Animal, Ghrelin, metabolism, pharmacology, therapeutic use, Growth Hormone, drug effects, metabolism, secretion, Heart Failure, drug therapy, physiopathology, Humans
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Apart from promoting GH secretion and to regulate appetite and metabolism, it has become increasingly clear that GH secretagogues (GHS) and ghrelin exert a number of effects on the cardiovascular system. The main cardiovascular actions of GHS are possible inotropic effects, vasodilation, reported cardioprotective effects against ischemia, and in vitro effects on cardiomyocytes involving cell proliferation and anti-apoptotic actions. An interesting and intriguing feature of the cardiovascular effects of GHS is that they may be exerted directly on the heart and vasculature rather than being mediated by growth hormone. Evidence to suggest this is the finding of GHS binding sites on cardiomyocytes and the fact that some of the effects of GHS can be expressed also in the absence of GH. Taken together, these results offer an interesting perspective on the future where further studies aiming at evaluating a role of GHS and ghrelin in the treatment of cardiovascular disease are warranted.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?